About Technology Issues FAQ

Links

Should 5-Hydroxytryptamine-3 Receptor Antagonists Be Administered Beyond 24 Hours After Chemotherapy to Prevent Delayed Emesis? Systematic Re-Evaluation of Clinical Evidence and Drug Cost Implications

Type: (null)
Journal: Journal of Clinical Oncology
Year: 2005
Pages: 23, 1289-1294

Should 5-Hydroxytryptamine-3 Receptor Antagonists Be Administered Beyond 24 Hours After Chemotherapy to Prevent Delayed Emesis? Systematic Re-Evaluation of Clinical Evidence and Drug Cost Implications — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.